Divya Kumar

Also affiliated with Amrita Institute of Medical Sciences and Research Centre, Sri Ramachandra Institute of Higher Education and Research, London School of Hygiene & Tropical Medicine, Sangath, Stanford University

MedicineNursingNeuroscienceSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’ study”.

Phase 2, randomized multi oral immunotherapy with omalizumab ‘real life’ study

Allergy(2022)10.1111/all.15217

N/A

1.1DataRank · unranked

48 citations

Divya Kumar, Shu Cao, Natasha Purington, Andrew Long, Vanitha Sampath +5 more

Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy study

Frontiers in Immunology(2025)10.3389/fimmu.2025.1655975

N/A

0.104DataRank · unranked

1 citations

Andrea Fernandes, Monali Manohar, Shu Cao, Sheena Gupta, Ella Parsons +18 more